Japan’s Shionogi Says Its Covid Pill’s Sales May Hit $2 Billion

Japanese drugmaker Shionogi & Co. Ltd. says sales of the Covid pill it is developing could reach $2 billion drug. The company expects to have late-stage trial data in Japan by December and plans to …